Fund Holdings — Lynx1 Capital Management LP

Total Portfolio Value:
$282.24M
Total Bought:
$59.83M
Total Sold:
$8.77M
Net Transaction:
+$51.06M
Notable People:
Weston Agnew Nichols
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V1,206,7071,793,866+587,159$71.40M$89.62M31.75%+$18.22M
Stoke Therapeutics, Inc.(STOK)5,185,1915,187,191+2,000$70.05M$63.75M22.59%-$6.30M
C4 Therapeutics, Inc.(CCCC)6,880,5276,880,5270$31.79M$39.22M13.90%+$7.43M
GH Research PLC(GHRS)3,966,7264,195,894+229,168$46.25M$28.07M9.95%-$18.18M
TScan Therapeutics, Inc.(TCRX)5,224,6005,224,6000$30.56M$26.02M9.22%-$4.55M
Allogene Therapeutics Inc2,228,2956,202,374+3,974,079$5.19M$17.37M6.15%+$12.17M
Cullinan Therapeutics, Inc.(CGEM)377,323410,830+33,507$6.58M$6.88M2.44%+$296.8K
Passage Bio, Inc.(PASG)5,057,6298,426,955+3,369,326$4.02M$5.90M2.09%+$1.88M
iBio, Inc.CON NEW(IBIO)600,000862,279+262,279$1.27M$1.91M0.68%+$648.3K
Caribou Biosciences, Inc.(CRBU)0680,189+680,189$0$1.33M0.47%+$1.33M
Kodiak Sciences Inc.(KOD)0271,177+271,177$0$707.8K0.25%+$707.8K
Pieris Pharmaceuticals Inc43,49937,436-6,063$426.8K$620.7K0.22%+$193.9K
Centessa Pharmaceuticals PlcADS17,40017,4000$157.1K$278.2K0.10%+$121.1K
Bionomics LimitedADS599,673549,673-50,000$459.9K$241.5K0.09%-$218.5K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)9,5008,231-1,269$177.4K$205.7K0.07%+$28.3K
Tenax Therapeutics, Inc.(TENX)014,751+14,751$0$51.0K0.02%+$51.0K
Century Therapeutics, Inc.(IPSC)019,028+19,028$0$32.5K0.01%+$32.5K
Yarrow Bioscience Inc(YARW)16,19416,1940$31.9K$30.4K0.01%-$1.5K
Cabaletta Bio, Inc.(CABA)492,1030-492,103$3.68M$0—-$3.68M
Korro Bio, Inc.(KRRO)3,8000-3,800$128.7K$0—-$128.7K
Longboard Pharmaceuticals In167,3170-167,317$4.52M$0—-$4.52M
Page 1 of 1
Lynx1 Capital Management LP — 13F Holdings — Q3 2024 | TickerTrail